Header Logo

Connection

JADE WULFF to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications JADE WULFF has written about Protein Kinase Inhibitors.
JADE WULFF
Connection Strength
0.164
Protein Kinase Inhibitors
  1. Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions. Eur J Cancer. 2025 May 02; 220:115308.
    View in: PubMed
    Score: 0.164
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.